New book by Larry Connors Click here Improve your trading - See how
Sara Taillon, Nextrials' senior software engineer and development team lead, will participate in a panel discussion entitled "Local Labs" on Monday, September 22 at 3:30 p.m. CDT. During this session, participants will explore the elimination of manual lab data entry by leveraging the CDISC lab standard to significantly reduce entry errors and streamline data analysis. Other speakers include Brenda Gaines, CCDM, Manager, Clinical Data Coordination at Pfizer Inc., Joanna Tice, Lab Data Manager, Clinical Data Management at Human Genome Sciences Inc. and Balaka Sen at Schering Plough Research Institute.
Urmi Parkar, quality assurance manager at Nextrials, will participate in a second panel discussion entitled "Outsourcing Quality" on Tuesday, September 23 at 3:30 p.m. CDT. Other speakers include Bron Kisler, Director, Terminology & Strategic Alliances at CDISC, Edward Helton, Chief Scientist at SAS Institute in Regulatory at SAS Institute, Fred Wood, Principal Consultant at Octagon Research Solutions and Rhonda Facile, CDASH Program Director at CDISC.
The 2008 SCDM Fall Conference benefits professionals in the fields of clinical data management, clinical information technology, regulatory, systems validation, biostatistics, and industry service providers. Those interested in learning more about these seminars or in attending the conference can visit http://www.scdm.org.
About Nextrials, Inc.
Founded by pharmaceutical researchers in 1999, Nextrials offers today's most novel products and services for speeding the delivery of life-saving drugs and medical devices to market. Prism(R), its award-winning Electronic Data Capture (EDC) solution, has been used at over 1,000 research sites to streamline the initiation and management of clinical trials. The company is headquartered in the San Francisco Bay area. For more information, visit www.nextrials.com or call 925-355-3000. A podcast by co-founder and CEO James Rogers on the incorporation of electronic health records into the clinical trial process is also available at http://pharmavoice.com/podcasts.
SOURCE: Nextrials, Inc.
VOXUS, Inc. Rachel V. Berry, 253-853-5151, ext. 223 rberry@voxuspr.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
